Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.
Jorge J. Castillo,Thomas Guerrero-Garcia,Francesco Baldini,Emmanuelle Tchernonog,Guillaume Cartron,Slavisa Ninkovic,Kate Cwynarski,Daan Dierickx,Thomas Tousseyn,Frederick Lansigan, Yevgeny Linnik,Renzo Mogollon,José-Tomás Navarro,Adam J. Olszewski,John L. Reagan,Pasquale L. Fedele,Michael Gilbertson,George Grigoriadis,Michele Bibas BRITISH JOURNAL OF HAEMATOLOGY（2019）
关键词
plasmablastic lymphoma,bortezomib,chemotherapy,survival
AI 理解论文
溯源树
样例
